Europe requires a modern regulatory framework for clinical trials now


A harmonised, transparent and evenly implemented regulatory framework for clinical trials in the EU is vital if we want to maintain an innovative and viable bioscience industry that can compete globally. This will benefit patients by improving the development and access to innovative medicines while contributing to the goals of the EU 2020 strategy – Europe becoming the foremost knowledge-based economy in the world, a true ‘Innovation Union’